Estimation of PC12 cell numbers with acid phosphatase assay and mitochondrial dehydrogenase assay: Dopamine interferes with assay based on tetrazolium

Experimental Brain Research

Volumn 124, Issue 2, 1999, Pages 145-150

  Si, Fengqin ^a   Shin, Seon H ^a   Biedermann, Alyson ^a   Ross, Gregory M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Acid phosphatase activity; Ascorbate; Catecholamine; Mitochondrial dehydrogenase activity

Indexed keywords

4 NITROPHENYL PHOSPHATE; ACID PHOSPHATASE; ADRENALIN; DOPAMINE; FORMAZAN; NORADRENALIN; OXIDOREDUCTASE; TETRAZOLIUM;

ACCURACY; ANIMAL CELL; ARTICLE; CELL COUNT; CELL STRAIN; CONTROLLED STUDY; ENZYME ASSAY; MICROSCOPY; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; RAT;

ACID PHOSPHATASE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CELL COUNT; DOPAMINE; ENZYME TESTS; EPINEPHRINE; FALSE POSITIVE REACTIONS; MITOCHONDRIA; NEURONS; NOREPINEPHRINE; OXIDOREDUCTASES; PC12 CELLS; RATS; SENSITIVITY AND SPECIFICITY; TETRAZOLIUM SALTS;

EID: 0033012095     PISSN: 00144819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002210050608     Document Type: Article

References (23)

1. Altman FP (1976) Tetrazolium salts and formazans. Prog Histochem Cytochem 9:1-56
2. Berridge MV, Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303:474-482
3. Burdon RH, Gill V, Rice-Evans C (1993) Reduction of a tetrazolium salt and superoxide generation in human tumor cells (He-La). Free Radic Res Commun 18:369-380
4. Connolly DT, Knight MB, Harakas NK, Wittwer AJ, Feder J (1986) Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem 152:136-140
5. Cory AH, Owen TC, Barltrop JA, Cory JG (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3:207-212
6. Feng J, Melcher AH, Brunette DM, Moe HK (1977) Determination of L-ascorbate levels in culture medium concentrations in commercial media and maintenance of levels under conditions of organ culture. In Vitro 13:91-99
7. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 72: 2424-2428
8. Jenner P, Schapira AHV, Marsden CD (1992) New insights into the cause of Parkinson's disease. Neurology 42:2241-2250
9. Katyare SS, Bangur CS, Howland JL (1994) Is respiratory activity in the brain mitochondria responsive to thyroid hormone action? A critical re-evaluation. Biochem J 302:857-860
10. Liu Y, Peterson DA, Kimura H, Schubert D (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69:581-593
11. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
12. Riss TL, Moravec RA (1992) Comparison of MTT, XTT and a novel tetrazolium compound MTS for in vitro proliferation and chemosensitivity assays. Mol Biol Cell [Suppl] 3:184a
13. Ross GM, McCarry BE, Thakur S, Mishra RK (1993) Identification of novel catecholamine absorbing proteins in the central nervous system. J Mol Neurosci 4:141-148
14. Ross GM, McCarry BE, Mishra RK (1995) Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene. J Neurochem 65:2783-2789
15. Sakagami H, Satoh K, Ohata H, Takahashi H, Yoshida H, Iida M, Kuribayashi N, Sakagami T, Momose K, Takeda M (1996) Relationship between ascorbyl radical intensity and apoptosis-inducing activity. Anticancer Res 16:2635-2644
16. Shearman MS, Hawtin SR, Tailor VJ (1995) The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. J Neurochem 65:218-227
17. Shin SH, Hanna SF, Hong M, Jhamandas K (1990) Re-examination of dopamine as the prolactin-release inhibiting factor (PIF): supplementary agent may be required for dopamine to function as the physiological PIF. Can J Physiol Pharmacol 68: 1226-1230
18. Shin SH, Si F, Chang A, Ross GM (1997) Dopamine requires ascorbate to be the prolactin release-inhibiting factor. Am J Physiol 273 (Endocrinol Metab 36):E593-E598
19. Si F, Ross GM, Shin SH (1998) Glutathione protects PC12 cells from ascorbate-and dopamine-induced apoptosis. Exp Brain Res 123:263-268
20. Slater TF, Sawyer B, Strauli U (1963) Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta 77:383-393
21. + by dopamine neurons is required for MPTP toxicity: studies in brain synaptosomes and PC12 cells. In: Markey SP, Castagonli N, Trevor AJ, Kopin IJ (eds) MPTP: neurotoxin producing Parkinson's syyndrome. Academic Press, Florida, pp 191-201
22. Ueda Y, Walsh E, Nakanishi H, Yoshida K (1994) A colorometric assay method for the evaluation of neurotrophic activity in virto. Neurosci Lett 165:203-220
23. Velex-Pardo C, Jimenez Del Rio M, Verschueren H, Ebinger G, Vauquelin G (1997) Dopamine and iron induce apoptosis in PC12 cells. Pharmacol Toxicol 80:76-84